Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Oligoclonal restriction of antiviral immunoreaction in oligoclonal band-negative MS patients.
Comparison of clinical characteristics between neuromyelitis optica spectrum disorders with and without spinal cord atrophy.
MRI relaxation in the presence of fictitious fields correlates with myelin content in normal rat brain.
Inflammation, Iron, Energy Failure, and Oxidative Stress in the Pathogenesis of Multiple Sclerosis.
Inter- and intra-laboratory comparison of JC polyomavirus antibody testing using two different virus-like particle (VLP)-based assays.
The contribution of immune and glial cell types in experimental autoimmune encephalomyelitis and multiple sclerosis.
Concise Review: Modeling Multiple Sclerosis With Stem Cell Biological Platforms: Toward Functional Validation of Cellular and Molecular Phenotypes in Inflammation-Induced Neurodegeneration.
Predicting Breakdown of the Blood-Brain Barrier in Multiple Sclerosis without Contrast Agents.
Multiple sclerosis: Cognitive training provides lasting benefits for patients with multiple sclerosis.
Two assessments to evaluate imagery ability: translation, test-retest reliability and concurrent validity of the German KVIQ and Imaprax.
Robust Non-Local Multi-Atlas Segmentation of the Optic Nerve.
Imaging in multiple sclerosis and related disorders.
Imaging in multiple sclerosis and related disorders.
Direct visualization of membrane architecture of myelinating cells in transgenic mice expressing membrane-anchored EGFP.
Regulatory Lymphocytes Are Key Factors in MHC-Independent Resistance to EAE.
The First Sphingosine 1-Phosphate Lyase Inhibitors against Multiple Sclerosis: A Successful Drug Discovery Tale.
Regulatory B Cells in Experimental Autoimmune Encephalomyelitis (EAE).
Emergency medical care of multiple sclerosis patients: primary data from the mount sinai resource utilization in multiple sclerosis project.
Multiple sclerosis: Scoring system to predict response to IFN-β in patients with multiple sclerosis.
A guide to treating gait impairment with prolonged-release fampridine (Fampyra(®)) in patients with multiple sclerosis.
Differential efficacy of the TSPO ligands etifoxine and XBD-173 in two rodent models of Multiple Sclerosis.
The Diagnosis and Treatment of Optic Neuritis.
Analysis of tremor in multiple sclerosis using Hilbert-Huang Transform.
High in vitro immune reactivity to Escherichia coli in neuromyelitis optica patients is correlated with both neurological disabilities and elevated plasma lipopolysaccharide levels.
[Pathogenesis of chronic inflammatory demyelinating polyneuropathy].
Pages
« first
‹ previous
…
462
463
464
465
466
467
468
469
470
…
next ›
last »